<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kurolap A</submitter><funding>NHGRI NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>518-532</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8948158</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>109(3)</volume><pubmed_abstract>Cell adhesion molecules are membrane-bound proteins predominantly expressed in the central nervous system along principal axonal pathways with key roles in nervous system development, neural cell differentiation and migration, axonal growth and guidance, myelination, and synapse formation. Here, we describe ten affected individuals with bi-allelic variants in the neuronal cell adhesion molecule NRCAM that lead to a neurodevelopmental syndrome of varying severity; the individuals are from eight families. This syndrome is characterized by developmental delay/intellectual disability, hypotonia, peripheral neuropathy, and/or spasticity. Computational analyses of NRCAM variants, many of which cluster in the third fibronectin type III (Fn-III) domain, strongly suggest a deleterious effect on NRC</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity.</pubmed_title><pmcid>PMC8948158</pmcid><funding_grant_id>U01 HG007672</funding_grant_id><funding_grant_id>R01 NS106298</funding_grant_id><pubmed_authors>Gonzaga-Jauregui C</pubmed_authors><pubmed_authors>Rice J</pubmed_authors><pubmed_authors>Ast G</pubmed_authors><pubmed_authors>Undiagnosed Diseases Network</pubmed_authors><pubmed_authors>van Eyk CL</pubmed_authors><pubmed_authors>Mah JK</pubmed_authors><pubmed_authors>Atkinson D</pubmed_authors><pubmed_authors>Tammer L</pubmed_authors><pubmed_authors>Shashi V</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Kaslin J</pubmed_authors><pubmed_authors>Cope H</pubmed_authors><pubmed_authors>Candayan A</pubmed_authors><pubmed_authors>Bakhtiari S</pubmed_authors><pubmed_authors>Jordanova A</pubmed_authors><pubmed_authors>Kurolap A</pubmed_authors><pubmed_authors>Sency V</pubmed_authors><pubmed_authors>Glaser F</pubmed_authors><pubmed_authors>Xin B</pubmed_authors><pubmed_authors>Sullivan JA</pubmed_authors><pubmed_authors>Leibu R</pubmed_authors><pubmed_authors>Kreuder F</pubmed_authors><pubmed_authors>Parman Y</pubmed_authors><pubmed_authors>Elpeleg O</pubmed_authors><pubmed_authors>Ilivitzki A</pubmed_authors><pubmed_authors>Harel T</pubmed_authors><pubmed_authors>Battaloglu E</pubmed_authors><pubmed_authors>Innes AM</pubmed_authors><pubmed_authors>Kocasoy-Orhan E</pubmed_authors><pubmed_authors>Duvdevani MP</pubmed_authors><pubmed_authors>Colquhoun D</pubmed_authors><pubmed_authors>Kruer MC</pubmed_authors><pubmed_authors>Baris Feldman H</pubmed_authors><pubmed_authors>Soudry S</pubmed_authors><pubmed_authors>Douek AM</pubmed_authors><pubmed_authors>Fahey MC</pubmed_authors><pubmed_authors>Gecz J</pubmed_authors><pubmed_authors>Meiner V</pubmed_authors><pubmed_authors>Henry J</pubmed_authors><pubmed_authors>Wlodkowic D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity.</name><description>Cell adhesion molecules are membrane-bound proteins predominantly expressed in the central nervous system along principal axonal pathways with key roles in nervous system development, neural cell differentiation and migration, axonal growth and guidance, myelination, and synapse formation. Here, we describe ten affected individuals with bi-allelic variants in the neuronal cell adhesion molecule NRCAM that lead to a neurodevelopmental syndrome of varying severity; the individuals are from eight families. This syndrome is characterized by developmental delay/intellectual disability, hypotonia, peripheral neuropathy, and/or spasticity. Computational analyses of NRCAM variants, many of which cluster in the third fibronectin type III (Fn-III) domain, strongly suggest a deleterious effect on NRC</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-31T16:03:11.716Z</modification><creation>2025-02-19T01:27:26.612Z</creation></dates><accession>S-EPMC8948158</accession><cross_references><pubmed>35108495</pubmed><doi>10.1016/j.ajhg.2022.01.004</doi></cross_references></HashMap>